These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 582335)

  • 21. New indications for 6-azauridine treatment in man. A review.
    Elis J; Rasková H
    Eur J Clin Pharmacol; 1972 Mar; 4(2):77-81. PubMed ID: 4570456
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of psoriasis 1975.
    Van Scott EJ
    JAMA; 1976 Jan; 235(2):197-8. PubMed ID: 946030
    [No Abstract]   [Full Text] [Related]  

  • 23. Low dose azaribine in the treatment of psoriasis.
    Dantzig PI; McEvoy B; Mauro J; Rayhanzadeh S
    Br J Dermatol; 1974 Nov; 91(5):573-7. PubMed ID: 4611468
    [No Abstract]   [Full Text] [Related]  

  • 24. An appraisal of current systemic chemotherapy for psoriasis.
    Farber EM; Pearlman D; Abel EA
    Arch Dermatol; 1976 Nov; 112 Spec no():1679-88. PubMed ID: 793537
    [No Abstract]   [Full Text] [Related]  

  • 25. Nucleoside analogs in the treatment of nonneoplastic diseases.
    Calabresi P; Doolittle CH; Heppner GH; McDonald CJ
    Ann N Y Acad Sci; 1975 Aug; 255():190-201. PubMed ID: 1059354
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous uses of the antiproliferative drugs.
    McDonald CJ
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):934-9. PubMed ID: 4138632
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppressive agents in the treatment of psoriasis].
    Ruszczak Z
    Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862
    [No Abstract]   [Full Text] [Related]  

  • 28. The danger in food safety policies.
    Hall RH
    Can Med Assoc J; 1978 Jan; 118(1):83-7. PubMed ID: 620390
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody response in psoriatic patients treated with 6-azauridine-triacetate.
    Perlík F; Elis J; Kubíková M
    Eur J Clin Pharmacol; 1973 Aug; 6(2):141-3. PubMed ID: 4769697
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

  • 31. The regulatory role of the United States Food and Drug Administration.
    Ortiz EM
    J Reprod Med; 1972 Apr; 8(4):205-6. PubMed ID: 5029971
    [No Abstract]   [Full Text] [Related]  

  • 32. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 33. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sure cure: public policy on drug efficacy before 1962.
    Swann JP
    Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid peptides as drug products: FDA regulatory requirements.
    Hoiberg CP; Rapaka RS
    NIDA Res Monogr; 1986; 70():385-404. PubMed ID: 3093882
    [No Abstract]   [Full Text] [Related]  

  • 36. First biotech drug to treat psoriasis.
    Mitchell P
    Nat Biotechnol; 2002 Jul; 20(7):640-1. PubMed ID: 12089534
    [No Abstract]   [Full Text] [Related]  

  • 37. Fixing the drug laws.
    Kennedy D
    Science; 2007 Jun; 316(5832):1669. PubMed ID: 17588901
    [No Abstract]   [Full Text] [Related]  

  • 38. Challenging Food and Drug Administration interpretations of the Federal Food, Drug, and Cosmetic Act.
    Cooper RM
    Food Drug Law J; 2003; 58(1):1-8. PubMed ID: 12739579
    [No Abstract]   [Full Text] [Related]  

  • 39. Azaribine, homocystinemia, and thrombosis.
    Shupack JL; Grieco AJ; Epstein AM; Sansaricq C; Snyderman SE
    Arch Dermatol; 1977 Sep; 113(9):1301-2. PubMed ID: 578401
    [No Abstract]   [Full Text] [Related]  

  • 40. The food and drug legislation of 1906.
    Scheindlin S
    Mol Interv; 2008 Feb; 8(1):4-11. PubMed ID: 18332477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.